PROTHOR: A randomized controlled trial
This is an old revision of the document!
The PROTHOR Trial is open for participation. For each country a designated person will coordinate on a national Level. If you want to participate in this trial and don't know your national coordinator's name, please contact Thomas Kiss (prothor@peg-dresden.de)
Steering Committee:
gildacinnella@gmail.com
edmond.cohen@mountsinai.org
mohamedrefaateltahan@hotmail.com
luizfernandofalcao@gmail.com
c.gregoretti@gmail.com
mgranellg@hotmail.com
mgabreu@ukdd.de
thomas.hachenberg@med.ovgu.de
thomas.hachenberg@med.ovgu.de
jankovic.radmilo@gmail.com
m.w.hollmann@amc.uva.nl
KrasslerJ@fachkrankenhaus-coswig.de
thomas.kiss@ukdd.de
torsten.loop@uniklinik-freiburg.de
marc-joseph.licker@hcuge.ch
n.marczin@imperial.ac.uk
g.h.mills@sheffield.ac.uk
mtm9006@med.cornell.edu
ZNISNEVI@montefiore.org
ppelosi@hotmail.com
RRossaint@ukaachen.de
marcus.j.schultz@gmail.com
senturkm@istanbul.edu.tr
ary.neto2@einstein.br
paolo.severgnini@uninsubria.it
laszlo.szegedi@skynet.be
veghdr@gmail.com
gsvgasman@yahoo.com
ziteng1934@163.com
National Coordinators:
PROTHOR is an investigator-initiated study, there won't be any paying for patients inclusion to the centers. A co-authorship is granted for every 20 randomized patients. Furthermore, each center may run their own sub-study upon application to the PROTHOR steering committee.
The trial has been registered at clinicaltrials.gov with trial . ID NCT02963025